Jon Olson
Analyst · our Xilinx Investor Relations website. Now let me turn the call over to Jon Olson
Thank you, Maria. During today’s commentary, I will review our business results for the December quarter. I will conclude my remarks by providing guidance for the March quarter. Revenues in the December quarter of $458.4 million were down 5% sequentially from the prior quarter and down 3% from the same quarter of the prior year. The months of October and November were in line with our original guidance of approximately flat sales. In the month of December, however, we experienced appreciable weakness in sales across a broad base of end markets resulting in our guidance revision on December 16th. Continued cost reduction efforts contributed to improved gross and operating margins during the quarter. Gross margin of 63.9% was up 60 basis points from last quarter and in line with our guidance of 63% to 64%. It was also the highest gross margin we have reported in four years. Combined R & D and SG&A expense was $173 million, lower than our revised guidance of $175 million to $177 million. As a result, operating margin improved to 26.1%, up from 25.8 % reported in the prior quarter and the highest we have reported in three years. Net income during the quarter was $139 million or $0.51 per diluted share and was impacted by a couple of factors. First, we spent $146 million in cash to repurchase $241 million face value of convertible debentures. This resulted in a pre-tax gain of $89.7 million or $0.24 per diluted share after-tax. This unique opportunity to improve long-term shareholder value presented itself due to the unsettled credit markets causing the overall convertible debt market to trade at deep discounts. In the short-term, we view this as an excellent way to leverage our strong cash position. We also recorded a pre-tax impairment charge on investments of $19.5 million or $0.05 per diluted share after-tax primarily related to losses on a certain cash portfolio investment in the financial sector. Almost all of this impairment was due to the write-off of the remainder of a cash investment partially impaired last quarter. The bankruptcy was resolved in a manner that will make it unlikely that we will receive any value from this investment. Collectively, the $89.7 million pre-tax gain and the $19.5 million pre-tax charge represented approximately $0.19 per diluted share gain after-tax. Operating cash flow for the December quarter was $128.5 million before $11 million in CapEx. As I mentioned earlier, we paid $146.3 million in cash during the quarter to repurchase $241.1 million of convertible debentures. We also paid $38.4 million in cash dividends. The tax rate was 26.3% higher than our forecast of 21%. The tax rate was heavily impacted by the gain on repurchase of the convertible debentures, which is taxed at US rates. Partially offsetting the increase in tax due to the re-purchase of the convertible debt was the impact of the reinstatement of the Federal R&D tax credit made effective during this fiscal quarter. Let me now comment on the balance sheet. Cash investments decreased $94 million during the quarter to $1.7 billion. We now have approximately $760 million in convertible debt on our balance sheet and our net cash position is approximately $920 million. Day sales outstanding decreased two days in December quarter to 42 days. Inventory dollars at Xilinx increased by $8 million sequentially in the December quarter representing 82 days. This is up from 73 days in the prior quarter and up from 69 days in the same quarter a year ago. Worldwide distributors held 17 days in the December quarter down from 20 days in the prior quarter. Combined inventory days in the December quarter were 99, up six days from the prior quarter, but within our target of 90 to 100 days. New product sales increased 2% sequentially driven by exceptionally strong Virtex-5 sales, which Moshe will discuss in more detail. Mainstream and base products experienced sequential declines of 9% and 17% respectively. Sales from all geographies declined sequentially during the quarter. North American sales were down 4% with the largest declines coming from wired communication and audio/video broadcast, but partially offset by an increase in defense sales. Asia Pacific sales were down 1% as strong sales from wireless communications was offset by weak sales in other end markets. European sales were down 12% in the quarter with all major end markets declining during the quarter. Sales from Japan were down 4% sequentially with gains from Consumer and Automotive partially offset by declines in other end Markets. In terms of our vertical markets, sales from wireless communications were up more than 10% sequentially to comprise 18% of overall revenues. Our wireless strength was virtually all related to China 3G infrastructure build. Wireless communication revenues from North America, Europe and Japan were all flat sequentially. Approximately 70% of our Asia Pacific revenues currently come from wired and wireless communication applications. Overall, wired Communications declined approximately 10% quarter-to-quarter. Wired communication revenue in North America, Europe and Japan were all down sequentially. Of the total communications revenue for Xilinx about 40% are currently wireless applications and 60% are wired telecom and networking applications. The other standout this quarter was our Defense and Aerospace business, which is part of our industrial and other category. Defense sales increased nearly 20% sequentially to comprise 15% of total revenues. While we are expecting defense to be seasonally weak in the March quarter, we still believe that Defense/Aerospace is our most recessionary proof end market. We have a good backlog in defense business for the next fiscal year and the US Department of Defense has already increased its budget for the September ‘08 to ‘09 year and we expect to see our Aerospace/Defense market grow year-over-year. Unfortunately, declines in the industrial, scientific and medical and test and measurement areas in December quarter offset the increases in defense, so the overall category was flat sequentially. All other end market segments, which include audio/video broadcast, automotive, consumer, computing and storage, declined quarter-to-quarter. Let me now turn to guidance for the March quarter of fiscal 2009. First, PLDs and Xilinx specifically appear to be laggard into the cyclical downturn due to our limited consumer exposure. As Xilinx business begins to feel the full impact of the recessionary times, we are entering the quarter with significantly reduced backlog. Forecasts for the most of our major end market customers suggested the band environment will remain weak in the March quarter with customers working through internal inventory levels. Defense sales are expected to be seasonally weak in the March quarter, as I mentioned earlier. Additionally, while 3G activity in China remains healthy in the long-term, we are expecting to experience a pause in the March quarter with sales picking up again in the June quarter for wide-band CDMA and GSM orders. As a result, we are forecasting sales to be down 15% to 25% sequentially with sales from all geographies and end Markets down sequentially. Because our visibility is so limited, we are providing a larger than normal range for our sales guidance. In light of the current economic conditions coupled with our wide guidance range, we have decided to provide a business update this quarter on March 3rd. We don't plan to reinstate the business update practice but if circumstances warrant, we will make an exception. Gross margin is expected to be approximately 61% to 63%. Combined operating expenses including $1.4 million of amortization are expected to be approximately flat to slightly down from the December quarter. Other income and expense is expected to be a net expense of approximately $3 million. The share count is expected to be approximately 275 million shares. And the tax rate for Q4 of our fiscal 2009 will be 21%. Let me now turn the call over to Moshe.